Latest Breaking News On - David melles - Page 1 : comparemela.com

BetterLife Announces Intent to Complete Private Placement

VANCOUVER, British Columbia, May 03, 2024 (GLOBE NEWSWIRE) BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:.

British columbiaUnited kingdomBetterlife pharmaDavid mellesBetterlife pharma incQlife pharmaNon brokered private placementPrivate placementInvestor relations managerCanadian stock exchange betr cnBetterlife pharma inc

BetterLife Announces Intent to Complete Private Placement of Units

BetterLife Announces Intent to Complete Private Placement of Units
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

British columbiaUnited kingdomBetterlife pharmaDavid mellesBetterlife pharma incLife announces intentComplete private placementQlife pharmaNon brokered private placementPrivate placementInvestor relations manager

BetterLife Advances BETR-001 IND-enabling Studies

BetterLife Advances BETR-001 IND-enabling Studies
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

British columbiaUnited kingdomAhmad doroudianBetterlife pharmaDavid mellesBetterlife pharma incConvertible debenturesPrivate placementsQlife pharmaInvestor relations manager

BetterLife To Present at the 2024 Bloom Burton & Co Healthcare Investor Conference

VANCOUVER, British Columbia, April 11, 2024 BetterLife Pharma Inc. , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental.

United kingdomBritish columbiaAhmad doroudianDavid mellesBetterlife pharmaHooshmand sheshbaradaranInvestment industry regulatory organization of canadaMetro toronto convention centre north building onBloom burton coCanadian investor protection fundBc small claims courtBloom burton securities incBetterlife pharma incQlife pharmaChief executive officerChief operating officer

BetterLife Announces Closing of $1 168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001

VANCOUVER, British Columbia, April 03, 2024 BetterLife Pharma Inc. , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental.

United kingdomBritish columbiaAhmad doroudianDavid mellesSteven sanghaBetterlife pharmaBetterlife pharma incQlife pharmaConvertible debenturesChief executive officerMultilateral instrumentInvestor relations